In agreement with the results obtained by other authors that have analyzed the immunohistochemical expression of PIM-1 in HNSCC tumors [13, 15, 16], we did not find a relationship between the transcriptional expression of PIM-1 and clinicopathological variables such as tumor extension or histological grade. The gene discussed is PIM1; the disease is neoplasm.